前庭动节律管理:时间问题
Philipp Krisai1, Michael Kühne1
1Department of Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, University of Basel, Petersgraben 4, 4031 Basel, Switzerland.
概括
对心房动 (AF) 的节律控制正在取得进展,导管切除 (CA) 在早期和复杂病例中显示出好处. 本综述总结了目前关于整个AF疾病过程中的节律控制策略的证据.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
背景情况:
- 前庭动 (AF) 的管理已经发展,强调节律控制.
- 导管切除 (CA) 越来越多地被认为是早期和初级节律控制策略中的好处.
- 在AF持续时间较长和并发症,特别是心力衰竭的患者中,CA的作用需要进一步研究.
研究的目的:
- 审查当前关于心房动中节律控制策略的证据.
- 分析AF病程不同阶段节律控制的有效性.
- 要突出导管切除在各种AF患者群体中的作用.
主要方法:
- 对心房动中节律控制研究的文献综述.
- 关于早期节律控制策略的证据综合.
- 分析了在不同AF患者群体中评估导管切除的研究.
主要成果:
- 早期节律控制和CA的主要节律控制显示出显著的益处.
- 证据表明,即使在AF持续时间较长和心力衰竭的患者中,CA的疗效也很高.
- 该审查综合了整个AF疾病谱的发现.
结论:
- 节律控制,特别是导管切除,是现代心房动管理的基石.
- 及时的节律控制策略对于优化患者的治疗结果至关重要.
- 进一步的研究支持CA在复杂心房的病例中不断扩大的作用.
相关概念视频
Disturbances in Heart Rhythm
924
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
924
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
941
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
941
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
804
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
804
Mechanism of Cardiac Arrhythmias
908
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
908
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
720
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
720
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K


